Perdoceo Q3 revenue rises 24.8% to $211.9 million; EPS $0.60 vs $0.57
Perdoceo reported third-quarter 2025 revenue up 24.8% to $211.9 million and GAAP diluted earnings per share of $0.60, compared with $0.57 a year earlier, and provided full-year 2025 GAAP EPS guidance of $2.35 to $2.37. The results include the USAHS acquisition completed on December 2, 2024, and the company returned $30.3 million to shareholders in the quarter through buybacks and dividends.
Key points
- Q3 revenue rose 24.8% to $211.9 million; operating income rose 13.8% to $51.0 million.
- Q3 GAAP diluted EPS was $0.60 versus $0.57; adjusted diluted EPS was $0.65 versus $0.59.
- Full-year 2025 GAAP EPS outlook is $2.35 to $2.37, versus $2.19 for 2024; Q4 outlook is $0.48 to $0.50 versus $0.47.
- Board declared a quarterly dividend of $0.15 per share, payable December 12, 2025.
The filing
Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.